Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apogee Therapeutics Inc | 537,093 | 592,093 | +55,000 | $15.01M | $39.34M | 6.40% | +$24.34M |
| Xenon Pharmaceuticals Inc.(XENE) | 460,000 | 837,387 | +377,387 | $21.19M | $36.05M | 5.86% | +$14.86M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 100,000 | 115,000 | +15,000 | $23.14M | $30.71M | 4.99% | +$7.57M |
| Crinetics Pharmaceuticals In | 447,095 | 470,000 | +22,905 | $15.91M | $22.00M | 3.58% | +$6.09M |
| Autolus Therapeutics plcADS(AUTL) | 1,550,408 | 3,375,000 | +1,824,592 | $9.98M | $21.53M | 3.50% | +$11.55M |
| Celldex Therapeutics, Inc.(CLDX) | 400,000 | 510,000 | +110,000 | $15.86M | $21.40M | 3.48% | +$5.54M |
| Arcellx Inc COMMON STOCK | 340,000 | 300,000 | -40,000 | $18.87M | $20.86M | 3.39% | +$2.00M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 470,000 | +470,000 | $0 | $20.27M | 3.29% | +$20.27M |
| Inozyme Pharma Inc | 1,885,802 | 2,642,519 | +756,717 | $8.03M | $20.24M | 3.29% | +$12.21M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 1,900,000 | 1,400,000 | -500,000 | $19.84M | $19.75M | 3.21% | -$82.0K |
| BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO) | 0 | 0 | 0 | $20.58M | $18.30M | 2.97% | -$2.28M |
| Kura Oncology, Inc.(KURA) | 191,535 | 730,492 | +538,957 | $2.75M | $15.58M | 2.53% | +$12.83M |
| Spyre Therapeutics, Inc.(SYRE) | 517,554 | 410,000 | -107,554 | $11.14M | $15.55M | 2.53% | +$4.41M |
| Verona Pharma PlcADS | 563,824 | 817,833 | +254,009 | $11.21M | $13.16M | 2.14% | +$1.95M |
| BeOne Medicines AGADR(ONC) | 0 | 82,143 | +82,143 | $0 | $12.85M | 2.09% | +$12.85M |
| Cerevel Therapeutics Hldng I | 750,000 | 300,000 | -450,000 | $31.80M | $12.68M | 2.06% | -$19.12M |
| Nurix Therapeutics, Inc.(NRIX) | 690,112 | 810,253 | +120,141 | $7.12M | $11.91M | 1.94% | +$4.79M |
| Astria Therapeutics Inc | 1,466,465 | 845,606 | -620,859 | $11.26M | $11.90M | 1.94% | +$639.5K |
| Nuvalent Inc | 175,000 | 150,000 | -25,000 | $12.88M | $11.26M | 1.83% | -$1.61M |
| Axsome Therapeutics, Inc.(AXSM) | 50,000 | 139,758 | +89,758 | $3.98M | $11.15M | 1.81% | +$7.17M |
| Apellis Pharmaceuticals Inc COM | 75,000 | 165,000 | +90,000 | $4.49M | $9.70M | 1.58% | +$5.21M |
| Alnylam Pharmaceuticals, Inc.NOTE 1 000 9 1(ALNY) | 0 | 0 | 0 | $0 | $9.45M | 1.54% | +$9.45M |
| Centessa Pharmaceuticals PlcADS | 795,729 | 830,546 | +34,817 | $6.33M | $9.39M | 1.53% | +$3.05M |
| Immunovant, Inc.(IMVT) | 345,000 | 285,000 | -60,000 | $14.53M | $9.21M | 1.50% | -$5.33M |
| COMPASS Pathways plcADS(CMPS) | 550,000 | 1,027,868 | +477,868 | $4.81M | $8.55M | 1.39% | +$3.74M |
| Inari Med Inc | 20,000 | 175,000 | +155,000 | $1.30M | $8.40M | 1.37% | +$7.10M |
| Establishment Labs Holdings Inc.(ESTA) | 228,277 | 164,589 | -63,688 | $5.91M | $8.38M | 1.36% | +$2.47M |
| Geron Corporation(GERN) | 0 | 2,500,000 | +2,500,000 | $0 | $8.25M | 1.34% | +$8.25M |
| Morphic Hldg Inc | 42,670 | 225,000 | +182,330 | $1.23M | $7.92M | 1.29% | +$6.69M |
| Omeros CorpNOTE 5 250 2 1 | 0 | 0 | 0 | $3.60M | $7.63M | 1.24% | +$4.03M |
| Newamsterdam Pharma Company ORDINARY SHARES | 125,000 | 286,200 | +161,200 | $1.40M | $6.77M | 1.10% | +$5.37M |
| Elevation Oncology Inc | 0 | 1,268,825 | +1,268,825 | $0 | $6.51M | 1.06% | +$6.51M |
| Perspective Therapeutics, Inc.(CATX) | 0 | 5,100,000 | +5,100,000 | $0 | $6.07M | 0.99% | +$6.07M |
| Absci Corporation | 0 | 1,025,000 | +1,025,000 | $0 | $5.82M | 0.95% | +$5.82M |
| Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS) | 0 | 0 | 0 | $3.40M | $5.78M | 0.94% | +$2.38M |
| Savara Inc.(SVRA) | 1,150,000 | 1,150,000 | 0 | $5.41M | $5.73M | 0.93% | +$322.0K |
| Cytokinetics, Incorporated(CYTK) | 160,000 | 80,000 | -80,000 | $13.36M | $5.61M | 0.91% | -$7.75M |
| Vaxcyte, Inc.(PCVX) | 25,000 | 80,000 | +55,000 | $1.57M | $5.46M | 0.89% | +$3.89M |
| Roivant Sciences Ltd.SHS(ROIV) | 500,000 | 500,000 | 0 | $5.62M | $5.27M | 0.86% | -$345.0K |
| Fulcrum Therapeutics, Inc.(FULC) | 125,000 | 550,339 | +425,339 | $843.8K | $5.20M | 0.84% | +$4.35M |
| Springworks Therapeutics Inc | 100,000 | 100,000 | 0 | $3.65M | $4.92M | 0.80% | +$1.27M |
| Krystal Biotech, Inc.(KRYS) | 25,000 | 26,746 | +1,746 | $3.10M | $4.76M | 0.77% | +$1.66M |
| Mersana Therapeutics Inc | 1,000,000 | 1,000,000 | 0 | $2.32M | $4.48M | 0.73% | +$2.16M |
| Cullinan Therapeutics, Inc.(CGEM) | 300,000 | 258,588 | -41,412 | $3.06M | $4.41M | 0.72% | +$1.35M |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 327,959 | +327,959 | $0 | $4.23M | 0.69% | +$4.23M |
| Viking Therapeutics, Inc.(VKTX) | 300,000 | 50,000 | -250,000 | $5.58M | $4.10M | 0.67% | -$1.48M |
| Rezolute, Inc.(RZLT) | 0 | 1,600,000 | +1,600,000 | $0 | $4.08M | 0.66% | +$4.08M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 50,000 | 160,000 | +110,000 | $1.48M | $4.02M | 0.65% | +$2.54M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 70,988 | 75,000 | +4,012 | $4.29M | $3.77M | 0.61% | -$519.7K |
| Immatics N.V.SHS(IMTX) | 200,000 | 350,000 | +150,000 | $2.11M | $3.68M | 0.60% | +$1.57M |
| Intra-Cellular Therapies Inc | 0 | 50,000 | +50,000 | $0 | $3.46M | 0.56% | +$3.46M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 0 | 120,000 | +120,000 | $0 | $3.43M | 0.56% | +$3.43M |
| Nextcure Inc | 0 | 1,359,037 | +1,359,037 | $0 | $3.03M | 0.49% | +$3.03M |
| Terns Pharmaceuticals Inc | 66,000 | 450,000 | +384,000 | $428.3K | $2.95M | 0.48% | +$2.52M |
| Protagonist Therapeutics Inc | 0 | 100,000 | +100,000 | $0 | $2.89M | 0.47% | +$2.89M |
| Helix Acquisition Corp IiCL A | 0 | 250,000 | +250,000 | $0 | $2.59M | 0.42% | +$2.59M |
| REGENXBIO Inc.(RGNX) | 0 | 110,000 | +110,000 | $0 | $2.32M | 0.38% | +$2.32M |
| Newamsterdam Pharma CompanyW EXP 11 22 202 *W EXP 99/99/999 | 137,000 | 202,599 | +65,599 | $428.8K | $2.24M | 0.36% | +$1.81M |
| Alkermes plcSHS(ALKS) | 356,384 | 75,000 | -281,384 | $9.89M | $2.03M | 0.33% | -$7.86M |
| Wave Life Sciences, Inc.SHS(WVE) | 0 | 286,585 | +286,585 | $0 | $1.77M | 0.29% | +$1.77M |
| Boston Scientific Corporation(BSX) | 0 | 25,000 | +25,000 | $0 | $1.71M | 0.28% | +$1.71M |
| Kezar Life Sciences Inc | 0 | 1,761,778 | +1,761,778 | $0 | $1.59M | 0.26% | +$1.59M |
| BridgeBio Pharma, Inc.(BBIO) | 80,000 | 50,000 | -30,000 | $3.23M | $1.55M | 0.25% | -$1.68M |
| Arya Sciences Acqu Corp IvCL A | 0 | 133,500 | +133,500 | $0 | $1.50M | 0.24% | +$1.50M |
| Tango Therapeutics, Inc.(TNGX) | 300,274 | 150,274 | -150,000 | $2.97M | $1.19M | 0.19% | -$1.78M |
| Zura Bio LimitedCL A(ZURA) | 0 | 450,009 | +450,009 | $0 | $1.16M | 0.19% | +$1.16M |
| Tourmaline Bio Inc | 68,081 | 50,000 | -18,081 | $1.78M | $1.15M | 0.19% | -$637.4K |
| Travere Therapeutics, Inc.(TVTX) | 0 | 125,000 | +125,000 | $0 | $963.8K | 0.16% | +$963.8K |
| Avrobio Inc | 500,000 | 700,000 | +200,000 | $680.0K | $896.0K | 0.15% | +$216.0K |
| Promis Neurosciences Inc | 265,958 | 265,958 | 0 | $305.9K | $508.0K | 0.08% | +$202.1K |
| Immatics N.VW EXP 07 01 202 | 187,204 | 187,204 | 0 | $546.6K | $486.7K | 0.08% | -$59.9K |
| Q32 Bio Inc.(QTTB) | 0 | 27,777 | +27,777 | $0 | $473.3K | 0.08% | +$473.3K |
| Context Therapeutics Inc.(CNTX) | 328,817 | 328,817 | 0 | $371.6K | $453.8K | 0.07% | +$82.2K |
| Passage Bio, Inc.(PASG) | 0 | 264,266 | +264,266 | $0 | $356.8K | 0.06% | +$356.8K |
| Avalo Therapeutics, Inc.(AVTX) | 0 | 10,000 | +10,000 | $0 | $217.5K | 0.04% | +$217.5K |
| Cassava Sciences IncW EXP 11 15 202 | 0 | 24,200 | +24,200 | $0 | $97.5K | 0.02% | +$97.5K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 75,000 | 75,000 | 0 | $36.8K | $22.4K | 0.00% | -$14.3K |
| ADC Therapeutics SASHS(ADCT) | 1,013,540 | 0 | -1,013,540 | $1.68M | $0 | — | -$1.68M |
| Allogene Therapeutics Inc | 400,000 | 0 | -400,000 | $1.28M | $0 | — | -$1.28M |
| Aravive Inc | 346,511 | 0 | -346,511 | $42.9K | $0 | — | -$42.9K |
| argenx SEADR(ARGX) | 7,500 | 0 | -7,500 | $2.85M | $0 | — | -$2.85M |
| Ascendis Pharma A/SADR(ASND) | 20,000 | 0 | -20,000 | $2.52M | $0 | — | -$2.52M |
| AstraZeneca PLCADR(AZN) | 60,000 | 0 | -60,000 | $4.04M | $0 | — | -$4.04M |
| Biohaven Ltd.(BHVN) | 20,866 | 0 | -20,866 | $893.1K | $0 | — | -$893.1K |
| Cymabay Therapeutics Inc | 1,090,441 | 0 | -1,090,441 | $25.76M | $0 | — | -$25.76M |
| Dynavax Technologies Corp | 300,000 | 0 | -300,000 | $4.19M | $0 | — | -$4.19M |
| EyePoint, Inc.(EYPT) | 109,900 | 0 | -109,900 | $2.54M | $0 | — | -$2.54M |
| Immunogen Inc | 1,404,608 | 0 | -1,404,608 | $41.65M | $0 | — | -$41.65M |
| InflaRx N.V.(IFRX) | 200,097 | 0 | -200,097 | $326.2K | $0 | — | -$326.2K |
| Kalvista Pharmaceuticals Inc | 125,969 | 0 | -125,969 | $1.54M | $0 | — | -$1.54M |
| LianMedicalADS(LIANY) | 3,779,694 | 0 | -3,779,694 | $16.90M | $0 | — | -$16.90M |
| Mirati Therapeutics Inc | 100,049 | 0 | -100,049 | $5.88M | $0 | — | -$5.88M |
| Neurocrine Biosciences, Inc.(NBIX) | 10,000 | 0 | -10,000 | $1.32M | $0 | — | -$1.32M |
| Nuvation Bio Inc.CL A(NUVB) | 250,000 | 0 | -250,000 | $377.5K | $0 | — | -$377.5K |
| Penumbra, Inc.(PEN) | 7,500 | 0 | -7,500 | $1.89M | $0 | — | -$1.89M |
| Puma Biotechnology, Inc.(PBYI) | 202,349 | 0 | -202,349 | $876.2K | $0 | — | -$876.2K |
| Relay Therapeutics, Inc.(RLAY) | 300,000 | 0 | -300,000 | $3.30M | $0 | — | -$3.30M |
| Viridian Therapeutics, Inc.(VRDN) | 50,000 | 0 | -50,000 | $1.09M | $0 | — | -$1.09M |